RA-9 is primarily used in research settings for its potent anti-inflammatory and immunomodulatory properties. It has shown promise in inhibiting key signaling pathways involved in chronic inflammatory diseases, making it a candidate for studying conditions like arthritis and inflammatory bowel disease. Due to its ability to suppress pro-inflammatory cytokines, RA-9 is utilized in cellular and animal models to evaluate therapeutic strategies for autoimmune disorders. Additionally, it has demonstrated anticancer activity in preclinical studies, particularly in inhibiting tumor growth and inducing apoptosis in certain cancer cell lines, supporting its use as a tool compound in oncology research.